← Open Payments lookup

BRENT WILLARD: Open Payments

NPI 1336551084 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$350 in 15 payments from 7 companies in 2025. Trend: 2023 $255 · 2024 $206 · 2025 $350

Food & beverage: $350
CompanyPaymentsAmount
Alkermes, Inc.7$164
Otsuka America Pharmaceutical, Inc.2$48
Neurocrine BioSciences, Inc.2$46
Teva Pharmaceuticals USA, Inc.1$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28
Janssen Pharmaceuticals, Inc1$19
E.R. Squibb & Sons, L.L.C.1$15

Products named: ARISTADA, INGREZZA, AUSTEDO XR, CAPLYTA, REXULTI, VIVITROL, ABILIFY ASIMTUFII, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.